Literature DB >> 8342310

[Long-term results following percutaneous facet coagulation].

J Jerosch1, W H Castro, H Halm, G Müller-Silvergieter.   

Abstract

UNLABELLED: 93 patients with a mean follow up of 73 months (30-133 months) after lumbar percutaneous radiofrequency denervation (PRFD) were evaluated. Mean age of the patients at time of surgery was 47 years (18-76 years). 54 patients had no lumbar spine surgery prior to facet denervation, 32 patients had one or multiple disc surgery prior to denervation, and 7 patients had spinal fusions. 51 patients were in the process of early retirement or already retired at time of surgery. Out of all 93 patients only 50% had significant pain relief immediately after PRFD. 3 months after PRFD the success rate dropped down to 38%. 6 years after surgery only 25% of all patients had long lasting good results. Patients who were pain free after facet infiltration had significant better initial results, but were similar to the others after 6 years. 6 out of 7 patients after lumbar spinal fusions demonstrated bad results. The worst results had those patients who had applied for early retirement (workmens compensation cases). In this group the recurrence rate was 74% 6 years after surgery. We found no correlation between the surgeon and the outcome. CLINICAL RELEVANCE: Without pain reduction after facet infiltration the success rate after PRFD is low. Spinal surgery prior to PRFD significantly reduces the success rate. The worst prognosis have workmans compensation cases. The recurrence rate is high within the first 6 months after PRDF.

Entities:  

Mesh:

Year:  1993        PMID: 8342310     DOI: 10.1055/s-2008-1040235

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  1 in total

1.  Percutaneous radiofrequency rhizotomy of lumbar spinal facets: the results of 46 cases.

Authors:  A I Göçer; E Cetinalp; M Tuna; F Ildan; H Bağdatoğlu; S Haciyakupoğlu
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.